Literature DB >> 16519533

Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.

Muthu Ramakrishnan1, Poul H Jensen, Derek Marsh.   

Abstract

Alpha-synuclein is a presynaptic protein, the A53T and A30P mutants of which are linked independently to early-onset familial Parkinson's disease. The association of wild-type alpha-synuclein with lipid membranes was characterized previously by electron spin resonance (ESR) spectroscopy with spin-labeled lipids [Ramakrishnan, M., Jensen, P. H., and Marsh, D. (2003) Biochemistry 42, 12919-12926]. Here, we study the interaction of the A53T and A30P alpha-synuclein mutants and a truncated form that lacks the acidic C-terminal domain with phosphatidylglycerol bilayer membranes, using anionic phospholipid spin labels. The strength of the interaction with phosphatidylglycerol membranes lies in the order: wild type approximately truncated > A53T > A30P > fibrils approximately 0, and only the truncated form interacts with phosphatidylcholine membranes. The selectivity of the interaction of the mutant alpha-synucleins with different spin-labeled lipid species is reduced considerably, relative to the wild-type protein, whereas that of the truncated protein is increased. Polarized infrared (IR) spectroscopy is used to study the interactions of the wild-type and truncated proteins with aligned lipid membranes and additionally to characterize the fibrillar form. Wild-type alpha-synuclein is natively unfolded in solution and acquires secondary structure upon binding to membranes containing phosphatidylglycerol. Up to 30-40% of the amide I band intensity of the membrane-bound wild-type and truncated proteins is attributable to beta-sheet structure, at the surface densities used for IR spectroscopy. The remainder is alpha-helix and residual unordered structure. Fibrillar alpha-synuclein contains 62% antiparallel beta-sheet and is oriented on the substrate surface but does not interact with deposited lipid membranes. The beta-sheet secondary-structural elements of the wild-type and truncated proteins are partially oriented on the surface of membranes with which they interact.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16519533     DOI: 10.1021/bi052344d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Adsorption of alpha-synuclein on lipid bilayers: modulating the structure and stability of protein assemblies.

Authors:  Farzin Haque; Anjan P Pandey; Lee R Cambrea; Jean-Christophe Rochet; Jennifer S Hovis
Journal:  J Phys Chem B       Date:  2010-03-25       Impact factor: 2.991

2.  Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.

Authors:  Ozlem Goker-Alpan; Barbara K Stubblefield; Benoit I Giasson; Ellen Sidransky
Journal:  Acta Neuropathol       Date:  2010-09-14       Impact factor: 17.088

3.  Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.

Authors:  Frits Kamp; Nicole Exner; Anne Kathrin Lutz; Nora Wender; Jan Hegermann; Bettina Brunner; Brigitte Nuscher; Tim Bartels; Armin Giese; Klaus Beyer; Stefan Eimer; Konstanze F Winklhofer; Christian Haass
Journal:  EMBO J       Date:  2010-09-14       Impact factor: 11.598

4.  Lack of alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Susan A Austin; Lalida Rojanathammanee; Mikhail Y Golovko; Eric J Murphy; Colin K Combs
Journal:  Neurochem Res       Date:  2011-03-08       Impact factor: 3.996

5.  Determine both the conformation and orientation of a specific residue in α-synuclein(61-95) even in monolayer by 13C isotopic label and p-polarized multiple-angle incidence resolution spectrometry (pMAIRS).

Authors:  Chengshan Wang; Yiqun Zhou; Christopher Ewuola; Toyin Akinleye; Takeshi Hasegawa; Roger M Leblanc
Journal:  Anal Sci       Date:  2022-05-28       Impact factor: 1.967

Review 6.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

7.  Labeling proteins with fluorophore/thioamide Förster resonant energy transfer pairs by combining unnatural amino acid mutagenesis and native chemical ligation.

Authors:  Rebecca F Wissner; Solongo Batjargal; Colin M Fadzen; E James Petersson
Journal:  J Am Chem Soc       Date:  2013-04-17       Impact factor: 15.419

8.  Using leucine zipper to facilitate alpha-synuclein assembly.

Authors:  Peizhou Jiang; Li-wen Ko; Karen R Jansen; Todd E Golde; Shu-Hui Yen
Journal:  FASEB J       Date:  2008-05-20       Impact factor: 5.191

9.  α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.

Authors:  Roberto Di Maio; Paul J Barrett; Eric K Hoffman; Caitlyn W Barrett; Alevtina Zharikov; Anupom Borah; Xiaoping Hu; Jennifer McCoy; Charleen T Chu; Edward A Burton; Teresa G Hastings; J Timothy Greenamyre
Journal:  Sci Transl Med       Date:  2016-06-08       Impact factor: 17.956

10.  Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Lalida Rojanathammanee; Eric J Murphy; Colin K Combs
Journal:  J Neuroinflammation       Date:  2011-05-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.